0|23|Public
50|$|The Benghazi burner (Thermette) design {{originates}} as {{an independent}} invention in 1929 by John Ashley Hart. It uses an internally narrowing (conical) chimney and a construction of either copper or tin plate. The shape is a straight cylinder leading up to a flat top; the water spout also being on the flat <b>top.</b> <b>Pouring</b> is done with a fixed handle on the side, and the base can be removed. The Thermette is considered a New Zealand cultural icon.|$|R
50|$|Clarified {{butter is}} milk fat {{rendered}} from butter {{to separate the}} milk solids and water from the butterfat. Typically, it is produced by melting butter and allowing the components to separate by density. The water evaporates, some solids float {{to the surface and}} are skimmed off, and the remainder of the milk solids sink to the bottom and are left behind when the butter fat (which would then be on <b>top)</b> is <b>poured</b> off.|$|R
6000|$|He emptied {{his plate}} {{of meat and}} her plate into the frying pan, {{likewise}} the roll of butter and the slice on the table, and on <b>top</b> he <b>poured</b> {{the contents of the}} coffee canister. All this he carried into the back yard and dumped in the garbage can. The coffee pot he emptied into the sink. [...] "How much of the money you got left?" [...] he next wanted to know.|$|R
50|$|In aerobic conditions, yeast turns sugars into {{pyruvate}} then converts pyruvate {{into water}} and carbon dioxide. This process can carbonate beers. In commercial production, the yeast works in anaerobic conditions to convert pyruvate into ethanol, {{and does not}} carbonate beer. Beer is carbonated with pressurized CO2. When beer is poured, carbon dioxide that is dissolved in the beer forms bubbles. These bubbles grow and accelerate as they rise by feeding off of nearby smaller bubbles, a phenomenon known as Ostwald ripening. These larger bubbles lead to “coarser” foam on <b>top</b> of <b>poured</b> beer.|$|R
5000|$|A {{base layer}} of {{prepared}} dough is stretched in a suitable casserole previously greased with fat. It is then {{covered with the}} first of four layers of filling consisting of milk sodden chopped or ground walnuts, fresh quark cheese, milk sodden ground poppy seed and grated apples. The layer of filling is spread over the entire surface, followed by the second layer of dough, the second layer of filling and so on, until all four layers of filling are put on. The final layer of dough is <b>topped</b> with <b>poured</b> sour cream previously mixed with melted butter and/or egg.|$|R
50|$|In Ethiopia {{they use}} a {{slightly}} different variation, theirs having a separate spout lower on the pot for pouring out the coffee.In Eritrea the jebena has only one spout at the <b>top</b> where they <b>pour</b> {{in the water and}} grinds and pour out the coffee.There is a small restaurant in Ethiopia made in an image of an Ethiopian jebena figure.|$|R
50|$|At Pavilion Kleber, {{teams had}} to stack 364 {{champagne}} coupes into a 12-level pyramid {{with only one}} coupe on the <b>top</b> level, then <b>pour</b> the entire contents of a magnum of champagne onto {{the top of the}} pyramid - all without breaking any of the glasses - in order to receive their next clue. Every five minutes, teams would have to drink a coupe of champagne.|$|R
60|$|No {{brightness}} gleamed {{from their}} armour; no banners waved over their heads; no music sounded among their ranks. Backed by the dreary woods, which still disgorged unceasing {{additions to the}} warlike multitude already encamped; surrounded by the desolate crags which showed dim, wild, and majestic through {{the darkness of the}} mist; covered with the dusky clouds which hovered motionless over the barren mountain <b>tops,</b> and <b>poured</b> their stormy waters on the uncultivated plains--all that the appearance of the Goths had of solemnity in itself was in awful harmony with the cold and mournful aspect that the face of Nature had assumed. Silent--menacing--dark,--the army looked the fit embodiment of its leader's tremendous purpose--the subjugation of Rome.|$|R
50|$|The {{monument}} is {{the tallest}} unreinforced concrete {{structure in the}} world. No steel was used to reinforce the concrete walls below its pyramidal <b>top.</b> As one <b>pour</b> was completed, large chunks of limestone were left projecting up to connect {{it to the next}} pour above. It is also the tallest concrete obelisk in the world. It is the second tallest obelisk in the world after the Washington Monument.|$|R
60|$|To raise Water from Wells for Cattle.--By hand.--Let one man {{stand in}} the water, or just above it; another 5 feet higher; and again another higher still, if {{the depth of the}} well {{requires}} it. Then let the lowermost man dip a bucket in the water, and pass it from hand to hand upwards; the <b>top</b> man <b>pours</b> the water into a trough, out of which the cattle drink. This trough may be simply a ditch scratched in the ground; a piece of canvas should be thrown over it, if the soil be sandy, to keep the water from being lost before the cattle have time to drink it. Thus Eyre speaks of watering his horse, out of his black servant's duck frock. Light gutta-percha buckets are very useful in temperate climates; and so are baskets, with oilcloth inside them.|$|R
30|$|The {{standard}} test for density, absorption, and voids, {{known as the}} “boil” test, determines the bulk density, absorption, and the volume percentage of permeable pore space (ASTM C 642 2006). The tests were performed on two sections of each core: one {{at the top of}} the core (near the pavement surface) and one directly under it. This was done in the hopes of showing that excessive drying or poor finishing techniques were causing an altered pore structure at the <b>top</b> of concrete <b>poured</b> in hot weather.|$|R
6000|$|A feigned, fictitious, artificial, supernatural, put-together-out-of-one's-head, thing. All this it must be, {{to begin}} with. The best type {{of it being}} the most {{practically}} fictile--a Greek vase. A thing which has two sides to be seen, two handles to be carried by, and a bottom to stand on, and a <b>top</b> to be <b>poured</b> out of, this, every right fiction is, whatever else it may be. Planned rigorously, rounded smoothly, balanced symmetrically, handled handily, lipped softly for pouring out oil and wine. Painted daintily at last with images of eternal things-- ...|$|R
50|$|Construction of {{the tower}} began on August 9, 1966 and was {{completed}} in approximately 18 months, {{just in time for}} the opening ceremonies for the fair held on April 6, 1968. The tophouse of the building was constructed at ground level and hoisted to the <b>top</b> of the <b>poured</b> concrete shaft. As the tophouse was being hoisted into place, on October 30, 1967 some of the cables used to hoist it snapped, leaving it resting on and precariously tilted on the Tower’s shaft. Eventually, oil field pipes were used in lieu of cables to complete the job.|$|R
50|$|The Detour was {{a choice}} between Tower or Terra. In Tower, teams had to stack 680 {{champagne}} coupes into a 15-level pyramid with only one coupe on the <b>top</b> level, then <b>pour</b> the entire contents of a magnum of Taittinger champagne onto {{the top of the}} pyramid - all without breaking any of the glasses - in order to receive their next clue. In Terra, teams searched the 1 sqkm acre winter-barren Taittinger vineyards for a cluster of wine grapes marked with the race flag. After finding the grapes, they returned it to the harvest foreman for their next clue.|$|R
50|$|In 1612, {{the ancient}} Roman {{aqueduct}} the Aqua Traiana was rebuilt by Pope Paul V and renamed the Acqua Paola; the restored aqueduct provided the fountain {{with a much}} more abundant source of water. The architect Carlo Maderno, nephew of the architect Domenico Fontana, was given the commission to redesign the fountain. He built a new octagonal base for the fountain on top of which he built a large irregular basin, decorated with steps and small columns, to hold the water. He kept the large lower stone vasque of the old fountain, and ornamented the pedestal above it with four stone scrolls. He removed the smaller upper vasque, {{and replaced it with}} an inverted vasque or cap like a mushroom, covered with stone scales. When the water spouted from the <b>top,</b> it <b>poured</b> down {{over the top of the}} upper vasque, its flow broken and made to sparkle by the stone scales. In addition, he removed the coats of arms of the three previous Popes and replaced them with plaques honoring his patron, Pope Paul V.|$|R
60|$|Most {{boys have}} {{observed}} an effect {{similar to this}} in casting lead. When you attempt to cast any thing of lead,--a cannon, for example, or anchor, or even a bullet,--you will observe that as the lead cools, the portion of it which comes {{at the top of}} the mould shrinks and falls in, forming a little pit or depression, which you have to fill up by pouring in a little more lead. The reason is, that lead, as well as most other melted substances, shrinks when it cools. In the case of the bullet, for instance, all the lead which forms the mass of the bullet within the mould shrinks. The effect of this would be to collapse the sides, were it not that the sides have already become solid by contact with the cold mould. But the lead at the <b>top,</b> having been <b>poured</b> in last, is still fluid; and so that settles down as the lead cools below, and forms the little pit or depression, which the boy presently fills up by pouring in a little more lead.|$|R
6000|$|... "And {{when the}} bad little pumpkin heard that, all its seeds fairly rattled {{in it for}} joy. The boy took out his knife, {{and the first thing}} the pumpkin knew he was cutting a kind of lid off the top of it; it was like getting scalped, but the pumpkin didn't mind it, because it was just the same as war. And when the boy got the <b>top</b> off he <b>poured</b> the seeds out, and began to scrape the inside as thin as he could without {{breaking}} through. It hurt awfully, and nothing but the hope of being a pumpkin-glory could have kept the little pumpkin quiet; but it didn't say a word, even after the boy had made a mouth for it, with two rows of splendid teeth, and it didn't cry with either of the eyes he made for it; just winked at him with one of them, and twisted its mouth to one side, so as to let him know it was in the joke; and the first thing it did when it got one was to turn up its nose at the good little pumpkin, which the boy's mother came into the barn to get." ...|$|R
5000|$|Christopher Lowe (Ian Bannen) is a {{frustrated}} middle management drone {{trapped in a}} loveless marriage with Mabel (Diana Dors). Bullied by his wife, and shown no respect by his son, he befriends Jim Underwood (Donald Pleasence) an old soldier now scratching out {{a living as a}} match and shoe lace seller.In an effort to impress, Lowe tells Underwood that he is a decorated soldier. To back up this lie, he tries to persuade the Proprietor to sell him a Distinguished Service Order medal. When the Proprietor asks that Lowe provide the certificate to prove he had previously been awarded the medal, Lowe steals the medal. Underwood is impressed by the medal, and asks Lowe to come to his house for tea. Once there he meets Underwood's daughter, Emily (Angela Pleasence). Over time Lowe is seduced by Emily's frankly rather creepy charms, and they start an affair.Emily then produces a miniature doll of Mabel, and holds a knife to it. She asks Lowe to order her to do his will. Lowe agrees that she should cut the doll. When she does, a drop of blood appears from its mouth. A disturbed Lowe dashes home to find Mabel dead. Underwood and Emily then appear at Lowe's home, and walk in {{to the sound of the}} wedding march.Later, Emily and Lowe are married. Lowe's son (played by the future writer John O'Farrell) and Jim Underwood attend the wedding. When the time comes to cut the cake, Emily asks all present whether they wish her to. They all agree and Emily brings the knife down, but rather than cut the cake, she cuts into the head of the decorative groom on <b>top.</b> Blood <b>pours</b> out of it, and Lowe falls on to the table, dead. Underwood and Emily explain to Lowe's son that they always answer the prayers of a child [...] "in one way or another".|$|R
40|$|SWIM is a Software Information Metacatalog that gathers {{detailed}} information about the software components and packages installed on a grid resource. Information is currently gathered for Executable and Linking Format (ELF) executables and shared libraries, Java classes, shell scripts, and Perl and Python modules. SWIM is built on <b>top</b> of the <b>POUR</b> framework, which is described in the preceding article. SWIM consists {{of a set of}} Perl modules for extracting software information from a system, an XML schema defining the format of data that can be added by users, and a POUR XML configuration file that describes how these elements are used to generate periodic, on-demand, and user-specified information. Periodic software information is derived mainly from the package managers used on each system. SWIM collects information from native package managers in FreeBSD, Solaris, and IRX as well as the RPM, Perl, and Python package managers on multiple platforms. Because not all software is available, or installed in package form, SWIM also crawls the set of relevant paths from the File System Hierarchy Standard that defines the standard file system structure used by all major UNIX distributions. Using these two techniques, the vast majority of software installed on a system can be located. SWIM computes the same information gathered by the periodic routines for specific files on specific hosts, and locates software on a system given only its name and type...|$|R
60|$|While {{the front}} {{part of the}} lime which you saw here was so highly ignited, I could at any moment touch {{the back of it}} without feeling any {{annoyance}} from the heat So, by having a chamber of lime of this sort, he is able to get a vessel to contain these metals with scarcely any loss of heat. He puts the blowpipes through these apertures, and sends down these gases upon the metals, which are gradually melted. He then puts in more metal through a hole at the top. The results of the combustion issue out of the aperture which you see represented. If there be strips of platinum, he pushes them through the mouth out of which the heated current is coming, and there they get red-hot and white-hot before they get into the bath of platinum. So he is able to fuse a large body of platinum in this manner. When the platinum is melted, he takes off the <b>top</b> and <b>pours</b> out from the bottom piece, like a crucible, and makes his cast. This is the furnace by which he fuses his forty pounds or fifty pounds of platinum at once. The metal is raised to a heat that no eye can bear. There is no light and shadow, no chiaro-oscuro there; all is the same intensity of glow. You look in, and you cannot see where the metal or the lime is; it is all as one. We have, therefore, a platform with a handle, which turns upon an axis, that coincides with the gutter that is formed for the pouring of the metal; and when all is known to be ready, by means of dark glasses, the workmen take off the top piece and lift up the handle, and the mould being then placed in a proper position, he knows that the issue of the metal will be exactly in the line of the axis. No injury has ever happened from the use of this plan. You know with what care it is necessary to carry such a vessel of mercury as we have here, for fear of turning it over on one side or the other; but if it be a vessel of melted platinum, the very greatest care must be used, because the substance is twice as heavy: yet no injury has been done to any of the workmen in this operation.|$|R
40|$|Objectives: In Streptococcus pyogenes (Group A Streptococcus, GAS), genes conferring efﬂux-mediated {{erythromycin}} (ERY) resistance (mefA/msr) {{are carried}} by functional prophages {{and may be}} associated with the tetracycline (TET) resistance determinant tetO. We sought to demonstrate the “ex vivo” lysogenic transfer of ERY and TET resistance genes among GAS. Methods: Forty-one ERY-susceptible GAS clinical isolates belonging to 12 different M-serotypes were used as recipients. The strain K 56 (Mserotype 12) was used as a standard indicator to prepare lawns and as a model recipient, while the ERY- and TET-resistant strain m 46 (Mserotype 4) was used as the donor of the tetO-mefA phage (phi-m 46). The donor was induced with 0. 2 mg/L mitomycin C. The culture supernatant was ﬁltered, treated with DNAse/RNAse, concentrated by PEG/NaCl precipitation, and then added to cultures of the recipient strains. After incubation, these mixtures were either added to supplemented molten <b>top</b> agar and <b>poured</b> over BHI agar plates for the visualisation and counting of plaques or plated on BHI agar plus erythromycin for the selection of ERY-resistant lysogenic clones. PCR was used to check for the emm-type, mefA, and tetO genes before and after lysogenic transfer experiments, and to detect phi-m 46 DNA in the supernatant of induced donor cultures. Results: The reference strain K 56 and 85. 4 % (n = 35) of the clinical isolates acquired ERY/TET resistance when infected with puriﬁed phim 46. All the M 1 (n = 7), M 12 (n = 6), M 75 (n = 2), M 18 (n = 1), M 94 (n = 1) and a fraction of the M 3 (5 / 7), M 4 (1 / 3), M 5 (1 / 2), M 6 (4 / 7) strains were lysogenised and converted to the ERY/TET resistant phenotype. No lysogenic clones were isolated {{in the case of the}} M 77, M 78 and M 89 recipients. Only M 12 strains and the totality of them were phi-m 46 -sensitive. Conclusions: The erythromycin and tetracycline resistance determinants carried by phage-m 46 can be efﬁciently transferred from a GAS strain to another by transduction. This is the ﬁrst direct demonstration of phagemediated horizontal resistance gene transfer in S. pyogenes. In the set of strains analyzed, an M-serotype dependent barrier to lysogenic transfer was not observed. The exclusive lysis susceptibility of the M 12 strains indicates that GAS with this serotype may represent the main responsible for the spread of this phage and the associated antibiotic resistance genes in S. pyogenes global population...|$|R
40|$|Orange (the {{brand name}} of France T el ecom) {{provides}} mobile network, television and Internet services. In order to o er these services, Orange has developed {{equipment such as}} the Livebox and the Set Top Box. However, to maintain the quality of service in these equipment, the company researches methods that allow the integration of new features in its equipments, {{as well as of}} services developed by third parties. To reach this purpose, Orange studies the possibility of introducing in their equipment an OSGi Service Platform, a dynamic module system for JavaTM, that supports the dynamic and transparent installation of components. This platform would allow the development of applications in a modular fashion, while o ering strong isolation mechanisms. This is necessary to open the Orange Platform for the software developed by third-party providers. In the meantime, recent studies have demonstrated that the OSGi Service Platform possesses a considerable number of security weaknesses. These vulnerabilities, if ignored, can be exploited by the malicious components to block or interfere with Orange services, or to obtain sensitive information from the Orange customers. Something that cannot be neglected by the enterprise. To avoid these problems, a validation platform will be developed that will analyze all the applications developed for Orange equipment, in order to ensure security properties, such as a non-malicious behavior. For example, the validation platform needs to detect a situation where the application wants to occupy a considerable part of the computational resources such as the processor, the RAM, the hard drive, among others. If the constructed platform built does not detect any malicious behavior, Orange will give a certi cation to the third-party application. Orange (le nom de marque de France T el ecom) fournit des services de r eseaux mobiles, t el evision et Internet. A n d'o rir ces services, Orange a d evelopp e des equipements tels que la Livebox et la Set <b>Top</b> Box. Cependant, <b>pour</b> maintenir la qualit e des services de ces equipements, l'entreprise recherche une m ethode qui permet l'int egration de nouvelles fonctionnalit es, et aussi de services d evelopp es par des tiers. Pour atteindre cet objectif, Orange etudie la possibilit e d'introduire dans ses equipements une plate-forme de services OSGi, un syst eme de modules dynamiques pour JavaTMqui o re la possibilit e de faire des installations dynamiques et transparentes des composants. Cette plate-forme permettra le d eveloppement modulaire des applications, qualit es n ecessaires a des developeurs tiers. Cependant, des etudes r ecentes ont d emontr e que la plate-forme OSGi poss ede un nombre consid erable de failles de s ecurit e. Ces vuln erabilit es, si elles sont ignor ees, peuvent ^etre utilise es par les composants malveillants pour bloquer ou interf erer avec les services d'Orange, ou pour obtenir des informations sensibles des clients Orange. Pour eviter ces probl emes, une plate-forme de validation sera d evelopp ee pour analyser toutes les applications d evelopp ees pour les equipements d'Orange a n d'assurer des propri et es de s ecurit e, comme un comportement non malveillant. Par exemple, la plateforme de validation doit d etecter une situation o u l'application veut occuper une partie consid erable des ressources de calcul comme par exemple le processeur, la m emoire vive, le disque dur, etc. Si la plate-forme construite ne trouve pas un comportement malveillant, Orange donnera une certi cation pour l'application...|$|R
40|$| {{fonction}} des profils d'expression de gènes des cellules saines et tumorales du patient. Les différences {{au niveau}} moléculaire entre tissus normaux et cancéreux sont exploitées afin de maximiser l'efficacité du traitement et minimiser sa toxicité. Cette thèse propose une approche pluridisciplinaire expérimentale et mathématique ayant pur but la détermination de stratégies anticancéreuses optimales sur base moléculaire. Cette approche est, tout d'abord, mise en œuvre pour la personnalisation de la chronothérapeutique des cancers, puis pour l'optimisation de la thérapie anticancéreuse dans le cas d'une mutation de l'oncogène SRC. La plupart des fonctions physiologiques chez les mammifères présentent une rythmicité circadienne, c'est-à-dire de période environ égale à 24 h. C'est par exemple le cas de l'alternance activité-repos, de la température corporelle, et de la concentration intracellulaire d'enzymes du métabolisme. Ces rythmes ont pour conséquence une variation de la toxicité et de l'efficacité d'un grand nombre de médicaments anticancéreux selon leur heure circadienne d'administration. De récentes études soulignent la nécessité d'adapter les schémas d'injection chronomodulés au profil moléculaire du patient. La première partie de cette thèse propose une approche combinée expérimentale et modélisatrice pour personnaliser sur base moléculaire la chronothérapie. La première étape a consisté en une preuve de concept impliquant des expérimentations in vitro sur cultures de cellules humaines et des travaux de modélisation in silico. Nous nous sommes focalisés sur l'étude de l'irinotecan (CPT 11), un médicament anticancéreux actuellement utilisé en clinique dans le traitement des cancers colorectaux, et présentant des rythmes de chronotoxicité et de chronoefficacité chez la souris et chez l'homme. Sa pharmacocinétique (PK) et pharmacodynamie (PD) moléculaires ont été étudiées dans la lignée de cellules d'adénocarcinome colorectal humain Caco- 2. Un modèle mathématique de la PK-PD moléculaire du CPT 11, à base d'équations différentielles ordinaires, a été conçu. Il a guidé l'expérimentation qui a été réalisée dans le but de d'évaluer les paramètres du modèle. L'utilisation de procédures d'optimisation, appliquées au modèle calibré aux données biologiques, a permis la conception de schéma d'exposition au CPT 11 théoriquement optimaux dans le cas particulier des cellules Caco- 2. Le CPT 11 s'est accumulé dans les cellules Caco- 2 où il a été biotransformé en son métabolite actif le SN 38, sous l'action des carboxylestérases (CES). La pré-incubation des cellules avec du verapamil, un inhibiteur non spécifique des transporteurs ABC (ATP-Binding Cassette) a permis la mise en évidence du rôle de ces pompes d'efflux ABC dans le transport du CPT 11. Après synchronisation des cellules par choc sérique, qui définit le temps circadien (CT) 0, des rythmes circadiens d'une période de 26 h 50 (SD 63 min) ont été mis en évidence pour l'expression de trois gènes de l'horloge circadienne: REV-ERBα, PER 2, et BMAL 1; et six gènes de la pharmacologie du CPT 11 : la cible du médicament la topoisomerase 1 (TOP 1), l'enzyme d'activation CES 2, l'enzyme de désactivation UGT 1 A 1, et les quatre transporteurs ABCB 1, ABCC 1, ABCC 2, ABCG 2. Au contraire, l'expression protéique et l'activité de la TOP 1 sont restées constantes. Enfin, la quantité de TOP 1 liée à l'ADN en présence de CPT 11, un marqueur de la PD du médicament, a été plus importante pour une exposition à CT 14 (47 ± 5. 2 % de la quantité totale de <b>TOP</b> 1), que <b>pour</b> une exposition à CT 28 (35. 5 ± 1. 8 %). Les paramètres du modèle mathématique de la PK-PD du CPT 11 ont ensuite été estimés par une approche de bootstrap, en utilisant des résultats expérimentaux obtenus sur les cellules Caco- 2, combinés aux données de la littérature. Ensuite, des algorithmes d'optimisation ont été utilisés pour concevoir les schémas d'exposition théoriquement optimaux des cellules Caco- 2 à l'irinotecan. Les cellules synchronisées par un choc sérique ont été considérées comme les cellules saines et les cellules non-synchronisées ont joué le rôle de cellules cancéreuses puisque l'organisation circadienne est souvent perturbée dans les tissus tumoraux. La stratégie thérapeutique optimale a été définie comme celle qui maximise l'efficacité sur les cellules cancéreuses, sous une contrainte de toxicité maximale sur les cellules saines. Les schémas d'administration considérés ont pris la forme d'une exposition à une concentration donnée de CPT 11, débutant à un CT particulier, sur une durée comprise entre 0 et 27 h. Les simulations numériques prédisent que toute dose de CPT 11 devrait être optimalement administrée sur une durée de 3 h 40 à 7 h 10, débutant entre CT 2 h 10 et CT 2 h 30, un intervalle de temps correspondant à 1 h 30 à 1 h 50 avant le minimum des rythmes de bioactivation du CPT 11 par les CES. Une interprétation clinique peut être établie en ramenant à 24 h ces résultats pour les cellules Caco- 2 qui présentent une période de 27 h. Ainsi, une administration optimale du CPT 11 chez le patient cancéreux résulterait en une présence du médicament dans le sang pendant 3 h 30 à 6 h 30, débutant de 1 h 30 à 1 h 40 avant le minimum des rythmes d'activité des CES chez le patient. La deuxième étape de nos travaux a consisté à adapter l'approche mise en œuvre pour optimiser l'exposition des cellules Caco- 2 au CPT 11, pour l'optimisation de l'administration du médicament chez la souris. Des études récentes mettent en évidence trois classes de chronotoxicité à l'irinotecan chez la souris. La classe 1, les souris de la lignée B 6 D 2 F 1 femelles, présentent la pire tolérabilité au CPT 11 après une administration à ZT 3, et la meilleure pour une administration à ZT 15, où ZT est le temps de Zeitgeber, ZT 0 définissant le début de la phase de lumière. La classe 2, les souris B 6 D 2 F 1 mâles, montrent une pire heure d'administration à ZT 23 et une meilleure à ZT 11. Enfin, la classe 3, les B 6 CBAF 1 femelles présentent la pire tolérabilité pour une injection à ZT 7, et la meilleure pour ZT 15. Nous avons entrepris une approche pluridisciplinaire in vivo et in silico dont le but est la caractérisation moléculaire des trois classes de chronotoxicité, ainsi que la conception de schémas optimaux d'administration pour chacune d'elles. Le modèle mathématique mis au point pour une population de cellules en culture a été adapté pour la construction d'un modèle "corps entier" à base physiologique de la PK-PD de l'irinotecan. Un ensemble de paramètres a été estimé pour la classe 2, en utilisant deux sortes de résultats expérimentaux: d'une part, les concentrations sanguines et tissulaires (foie, colon, moelle osseuse, tumeur) du CPT 11 administré aux pire et meilleure heures circadiennes de tolérabilité, et d'autre part, les variations circadiennes des protéines de la pharmacologie du médicament dans le foie et l'intestin. Le modèle ainsi calibré reproduit de façon satisfaisante les données biologiques. Cette étude est en cours pour les classes 1 et 3. Une fois les ensembles de paramètres validés pour chacune des trois classes, ils seront comparés entre eux pour mettre en évidence de possibles différences moléculaires. L'étape suivante consiste en l'application d'algorithmes d'optimisation sur le modèle corps entier pour définir des schémas d'administration chronomodulés optimaux pour chaque classe. La deuxième partie de cette thèse s'intéresse à l'étude de la tyrosine kinase SRC, dont l'expression est dérégulée dans de nombreux cancers. Des études récentes montrent un contrôle de SRC sur la voie mitochondriale de l'apoptose dans des fibroblastes de souris NIH- 3 T 3 transfectés avec l'oncogène v-src, cette régulation étant inexistante dans les cellules parentales. L'oncogène SRC active la voie RAS / RAK / MEK 1 / 2 / ERK 1 / 2 qui augmente la vitesse de phosphorylation de la protéine pro-apoptotique BIK, menant ainsi à sa dégradation par le protéasome. La faible expression de BIK résultant de ce mécanisme rendrait ainsi les cellules v-src résistantes à la plupart des stress apoptotiques. Notre étude a consisté à déterminer, par une approche combinée mathématique et expérimentale, les stratégies thérapeutiques optimales lorsque les cellules NIH- 3 T 3 parentales jouent le rôle de cellules saines, et les fibroblastes transformés celui de cellules cancéreuses. Pour cela, nous avons, tout d'abord, construit un modèle mathématique de la cinétique de BIK en conditions non-apoptotiques. L'estimation des paramètres de ce modèle, en utilisant des données expérimentales existantes, confirme que la phosphorylation de BIK sous le contrôle de SRC est inactive dans les cellules normales. L'étude exprimentale de l'évolution de BIK après le signal apoptotique que constitue une exposition à la staurosporine, démontre une relocalisation de BIK aux mitochondries, la concentration totale de la protéine restant constante durant le stress. Nous avons ensuite conçu un modèle mathématique de la voie mitochondriale de l'apoptose mettant en jeu les protéines anti-apoptotiques de type Bcl 2, les protéines effectrices de type BAX, les protéines BH 3 -only activatrices et les BH 3 -only sensibilisatrices. Un ensemble de paramètres a été déterminé pour les cellules NIH- 3 T 3 parentales, et celles transformées v-src, en comparant le modèle aux données expérimentales. Le modèle reproduit le fait expérimentalement démontré que la préincubation des cellules v-src avec un inhibiteur de la tyrosine kinase SRC, avant l'exposition à la staurosporine, annihile la résistance des fibroblastes transformés au stress apoptotique. Le modèle prédit que l'administration de l'ABT- 737, un inhibiteur de protéines anti-apoptotiques, avant l'exposition à la staurosporine, ne devrait pas être entreprise dans notre systéme biologique, ce qui a été expérimentalement validé. Enfin, le modèle a été utilisé dans des procédures d'optimisation pour déterminer la stratégie thérapeutique théoriquement optimale, lorsque les cellules normales et transformées sont exposées aux mêmes médicaments. Les combinaisons médicamenteuses considérées consiste en une exposition à la staurosporine, précédée d'une exposition à des répresseurs ou activateurs d'expression des protéines de la famille Bcl 2. La stratégie optimale est définie comme celle qui maximise le pourcentage de cellules apoptotiques dans les fibroblastes v-src, sous la contrainte que celui dans les cellules normales reste au-dessous d'un seuil de tolérabilité. Les simulations numériques nous permettent de conclure à une combinaison médicamenteuse optimale constituée d'une exposition à la staurosporine, précédée d'une exposition à un répresseur de l'expression de BAX (de manière à diminuer sa concentration en-dessous du seuil apoptotique dans les cellules normales, mais pas dans les cellules cancéreuses), combinée à un répresseur de BCL 2 ou un inhibiteur de tyrosines kinases SRC. Cette stratégie optimale aboutit à moins d' 1 % de cellules apoptotiques dans les cellules saines et plus de 98 % dans les cellules cancéreuses...|$|R

